Menu
Home
Herausgeber
Kategorien
Trend
Posteingang
Konto erstellen
Anmelden
Nederlands
English
Redefining biopharma innovation: Sanofi’s S$800m Modulus facility in Singapore
Edb.gov.sg
Abonnieren
0
Klicken Sie hier, um Edb.gov.sg zu abonnieren
Laden...
Letzten Dienstag um 08:00
Html
Text
#EDBWrapped2024: We’re ending 2024 with a recap of this year’s highlights!
View in browser here
.
#EDBWrapped2024:
EDB wishes all a delightful festive season and a Happy New Year! Here’s a recap of what you enjoyed reading in 2024
Check it out
Flexible, fast, and sustainable: How Sanofi is producing the next generation of vaccines and biopharma medicines
Read more
A US$263b opportunity: Three tech leaders say why Singapore is a gateway to SEA’s thriving digital economy
Get insights
Adding value and ‘not just costs’: Edwards LifeSciences’ Eric Monzon on Singapore’s MedTech ecosystem
Get insights
Febreze and Gorilla® Glass – Meet the MNCs making products for the world from Singapore
Learn more
Brought to you by
Singapore Economic Development Board
250 North Bridge Road
#28-00 Raffles City Tower
Singapore 179101
Connect with EDB
:
Scan QR code to connect on WeChat
You received this email because you signed up for regular updates on Asian business insights and news.
To contact us or unsubscribe, please use the links below.
Contact us
|
Update preferences
|
Unsubscribe
|
Privacy policy
|
Terms of use
Teilen auf
Laden...
Weitere Newsletter von
Edb.gov.sg
Redefining biopharma innovation: Sanofi’s S$800m Modulus facility in Singapore
Edb.gov.sg
Letzten Dienstag um 08:00
MedTech’s Top 30 firms say why they’re manufacturing in Singapore
Edb.gov.sg
Vor 25 Tagen
EDB’s S$32m plan to drive corporate venturing
Edb.gov.sg
2 Monate vor
Weitere Newsletter von Edb.gov.sg
Laden...
Verwandte Newsletter
[[subject]]
[[publisher.name]]
[[date]]
© 2024
Allgemeine Geschäftsbedingungen
Privatleben
Schließen
Home
Herausgeber
Kategorien
Trend
Posteingang
Konto erstellen
Anmelden
© 2024
Allgemeine Geschäftsbedingungen
Privatleben
Nederlands
English
